FreeTrials & Tribulations A comparison of study designs for estimating overdiagnosis in cancer screening May 03, 2019Vol.45 No.18By Barry Kramer and Philip C. Prorok
Conversation with The Cancer Letter Lee Schwartzberg tells us how three practices banded together to adapt to today’s cancer care and data revolution March 29, 2019Vol.45 No.13By Matthew Bin Han Ong
FreeTrials & Tribulations SWOG’s 1501 study takes aim at the silo wall between cardiology and oncology March 22, 2019Vol.45 No.12By Justin Floyd
Conversation with The Cancer LetterFree TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?” March 15, 2019Vol.45 No.11By Paul Goldberg
Conversation with The Cancer Letter CDC: HPV vaccine dramatically reduced HPV-related cervical precancers over 6 years March 01, 2019Vol.45 No.09By Claire Dietz
FreeTrials & Tribulations Glioblastoma patient is first to receive treatment under Right to Try. Our question is Why? February 01, 2019Vol.45 No.05By Kelly McBride Folkers and Alison Bateman-House
Trials & Tribulations Giving every patient an opportunity to participate in and benefit from cancer progress January 18, 2019Vol.45 No.03By Monica M. Bertagnolli
FreeTrials & Tribulations Deciphering genomic testing options for diverse patient populations in early-stage breast cancer November 16, 2018Vol.44 No.43By Adam Brufsky
Trials & Tribulations Biomarker linked to increased survival rates among certain brain tumor patients October 12, 2018Vol.44 No.38By Arnab Chakravarti
Trials & Tribulations How tumor-specific modulation frequencies were discovered October 05, 2018Vol.44 No.37By Boris C. Pasche
